Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve

Keyphrases

• First-degree Relatives 100%
• Cost-effectiveness Analysis 100%
• Patient Relatives 100%
• Bicuspid Aortic Valve 100%
• Echocardiographic Screening 30%
• Quality-adjusted Life Years 20%
• Cost-effectiveness 10%
• Clinically Significant 10%
• Malformation 10%
• Heritability 10%
• Economic Evaluation 10%
• Sensitivity Analysis 10%
• Decision-analytic Model 10%
• Probabilistic Sensitivity Analysis 10%
• Model Robustness 10%
• One-way Sensitivity Analysis 10%
• Dominant Strategy 10%
• Population-based 10%
• Life-threatening Complications 10%
• Heart Valve 10%
• Cost Savings 10%
• List Price 10%
• Screening Age 10%
• Incremental Effect 10%
• Congenital Heart 10%
• Health Gains 10%
• Cascade Screening 10%

Medicine and Dentistry

• Cost-Effectiveness Analysis 100%
• Bicuspid Aortic Valve 100%
• Health Care Cost 30%
• Index Case 30%
• Quality Adjusted Life Year 20%
• Echocardiography 10%
• Congenital Malformation 10%
• Heritability 10%
• Heart Valve 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Bicuspid Aortic Valve 100%
• Congenital Malformation 10%